Platelet-promoting APIs are a class of compounds used to treat a reduced number of platelets (thrombocytopenia) or decreased function (platelet insufficiency). Thrombocytopenia may result from insufficient platelet production, platelet retention by the spleen, increased platelet destruction or utilization, and dilution, and is clinically manifested by multiple ecchymoses, mucosal bleeding (epistaxis, gastrointestinal and urogenital tracts, and vaginal bleeding), massive postoperative bleeding, gastrointestinal massive bleeding, and bleeding within the central nervous system. Commonly used platelet-promoting APIs include diosmin and leucoson.

Protheragen-ING offers a full range of platelet-promoting APIs to support customer research worldwide.